Fagyas Miklós

1.

Enyedi, E. E., Petukhov, P. A., Kozuch, A. J., Dudek, S., Tóth, A., Fagyas, M., Danilov, S. M.: ACE Phenotyping in Human Blood and Tissues: revelation of ACE Outliers and Sex Differences in ACE Sialylation.
Biomedicines. 12 (5), 1-17, (article identifier: 940), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)

Q1 Medicine (miscellaneous) (2023)

2.

Tóth, E. L., Orbán-Kálmándi, R. A., Bagoly, Z., Lóczi, L., Deli, T., Török, O., Deliné Molnár, S., Baráth, S., Singh, P., Hevessy, Z., Katona, É., Fagyas, M., Szabó, A. Á., Molnár, S., Krasznai, Z. T.: Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Front. Immunol. 15, 1-10, (article identifier: 1329236), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology (2023)

Q1 Immunology and Allergy (2023)

3.

Sütő, R., Pócsi, M., Fagyas, M., Kalina, E., Fejes, Z., Szentkereszty, Z., Kappelmayer, J., Nagy, B. J.: Comparison of Different Vascular Biomarkers for Predicting In-Hospital Mortality in Severe SARS-CoV-2 Infection.
Microorganisms. 12 (1), 1-15, (article identifier: 229), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Microbiology (medical) (2023)

Q2 Microbiology (2023)

Q2 Virology (2023)

4.

Tóth, E., Fagyas, M., Nagy, B. J., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
GeroScience. 46 (2), 1561-1574, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Aging (2023)

Q1 Cardiology and Cardiovascular Medicine (2023)

D1 Complementary and Alternative Medicine (2023)

Q1 Geriatrics and Gerontology (2023)

D1 Veterinary (miscellaneous) (2023)

5.

Szabó, A. Á., Enyedi, E. E., Altorjay, I., Hajnal, P., Pintér, T. B., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Get reliable laboratory findings: how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?.
Clin. Chem. Lab. Med. 62 (7), 1393-1401, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry (medical) (2023)

Q1 Clinical Biochemistry (2023)

Q1 Medicine (miscellaneous) (2023)

6.

Bartha-Tatár, A., Sinkovits, G., Schnur, J., Maráczi, V., Dávid, M., Zsigmond, B., Rimanóczi, É., Szalay, B., Bíró, E., Bekő, G., Varga, P., Szabó, T., Fagyas, M., Fejes, Z., Kappelmayer, J., Nagy, B. J.: Prognostic Value of Baseline Serum Pro-Inflammatory Cytokines in Severe Multisystem Inflammatory Syndrome in Children.
J Clin Med. 13 (23), 1-14, (article identifier: 7177), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous) (2023)

7.

Stercel, V., Lóczi, L., Kadenczki, O., Nemes, É., Nagy, B. J., Hodossy-Takács, R., Szabó, A. Á., Fagyas, M., Kappelmayer, J., Szabó, T., Bagoly, Z.: Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease.
Front. Immunol. 14, 1-12, (article identifier: 1257072), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

Q1 Immunology and Allergy

8.

Kacsándi, D., Fagyas, M., Horváth, Á., Végh, E., Karancsiné Pusztai, A., Czókolyová, M., Soós, B., Szabó, A. Á., Hamar, A. B., Pethő, Z., Bodnár, N., Kerekes, G., Hódosi, K., Szamosi, S., Szűcs, G., Papp, Z., Szekanecz, Z.: Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.
Front. Med. 10, 1-8, (article identifier: 1226760), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

9.

Sütő, R., Pócsi, M., Szabo, Z., Fejes, Z., Ivády, G., Kerekes, G., Fagyas, M., Nagy, A. C., Szentkereszty, Z., Kappelmayer, J., Nagy, B. J.: Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia.
BMC Pulm Med. 23 (1), 1-11, 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Pulmonary and Respiratory Medicine

10.

Nagy, A. C., Majer, R., Boczán, J., Sipka, S. i., Szabó, A. Á., Enyedi, E. E., Tatai, O., Fagyas, M., Papp, Z., Csiba, L., Tóth, A.: Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood-Pressure-Lowering Effects in Newly Diagnosed Hypertensives.
Biomedicines. 11 (12), 1-13, (article identifier: 3323), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

11.

Szuromi, L., Hajas, O., Nagy-Baló, E., Forgács, I. N., Nagy, L. T., Fagyas, M., Tóth, A., Nagy, B. J., Kappelmayer, J., Csanádi, Z.: Long-Term Changes in the Biomarkers of Left Atrial Fibrosis after Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation.
Rev. Cardiovasc. Med. 24 (6), 171, (article identifier: 171), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Cardiology and Cardiovascular Medicine

Q3 Medicine (miscellaneous)

12.

Kozuch, A. J., Petukhov, P. A., Fagyas, M., Popova, I. A., Lindeblad, M. O., Bobkov, A. P., Kamalov, A. A., Tóth, A., Dudek, S., Danilov, S. M.: Urinary ACE Phenotyping as a Research and Diagnostic Tool: Identification of Sex-Dependent ACE Immunoreactivity.
Biomedicines. 11 (3), 1-19, (article identifier: 953), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

13.

Soós, B., Fagyas, M., Horváth, Á., Végh, E., Karancsiné Pusztai, A., Czókolyová, M., Csongrádi, A., Hamar, A. B., Pethő, Z., Bodnár, N., Kerekes, G., Hódosi, K., Szekanecz, É., Szamosi, S., Szántó, S., Szűcs, G., Papp, Z., Szekanecz, Z.: Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
Front. Med. 8, 1-11, (article identifier: 785744), 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

14.

Fagyas, M., Fejes, Z., Sütő, R., Nagy, Z., Székely, B., Pócsi, M., Ivády, G., Bíró, E., Bekő, G., Nagy, A. C., Kerekes, G., Szentkereszty, Z., Papp, Z., Tóth, A., Kappelmayer, J., Nagy, B. J.: Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
Int. J. Infect. Dis. 115, 8-16, 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Infectious Diseases

D1 Medicine (miscellaneous)

Q1 Microbiology (medical)

15.

Tangos, M., Budde, H., Kolijn, D., Sieme, M., Zhazykbayeva, S., Lódi, M., Herwig, M., Gömöri, K., Hassoun, R., Robinson, E. L., Meister, T. L., Jaquet, K., Kovács, Á., Mustroph, J., Evert, K., Babel, N., Fagyas, M., Lindner, D., Püschel, K., Westermann, D., Mannherz, H. G., Paneni, F., Pfaender, S., Tóth, A., Mügge, A., Sossalla, S., Hamdani, N.: SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress.
Int. J. Cardiol. 362, 196-205, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

16.

Fagyas, M., Nagy, B. J., Ráduly, A. P., Mányiné Siket, I., Mártha, L., Erdősi, G., Sipka, S. i., Enyedi, E. E., Szabó, A. Á., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bai, P., Bácsi, A., Tóth, A.: The majority of severe COVID-19 patients develop anti-cardiac autoantibodies.
GeroScience. 44, 2347-2360, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Aging

Q1 Cardiology and Cardiovascular Medicine

D1 Complementary and Alternative Medicine

Q1 Geriatrics and Gerontology

D1 Veterinary (miscellaneous)

17.

Nagy, B. J., Fejes, Z., Szentkereszty, Z., Sütő, R., Várkonyi, I., Ajzner, É., Kappelmayer, J., Papp, Z., Tóth, A., Fagyas, M.: A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
Int. J. Infect. Dis. 103, 412-414, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Infectious Diseases

D1 Medicine (miscellaneous)

D1 Microbiology (medical)

18.

Bódi, B., Pilz, P. M., Mártha, L., Lang, M., Hamza, O., Fagyas, M., Szabó, P. L., Abraham, D., Tóth, A., Podesser, B. K., Kiss, A., Papp, Z.: Alterations in ACE and ACE2 Activities and Cardiomyocyte Signaling Underlie Improved Myocardial Function in a Rat Model of Repeated Remote Ischemic Conditioning.
Int. J. Mol. Sci. 22 (20), 1-17, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

19.

Fagyas, M., Bánhegyi, V., Úri, K., Enyedi, A., Lizanecz, E., Mányiné Siket, I., Mártha, L., Fülöp, G. Á., Radovits, T., Pólos, M., Merkely, B., Kovács, Á., Szilvássy, Z., Ungvári, Z., Édes, I., Csanádi, Z., Boczán, J., Takács, I., Szabó, G., Balla, J., Balla, G., Seferović, P. M., Papp, Z., Tóth, A.: Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
GeroScience. 43 (5), 2289-2304, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Aging

Q1 Cardiology and Cardiovascular Medicine

D1 Complementary and Alternative Medicine

D1 Geriatrics and Gerontology

D1 Veterinary (miscellaneous)

20.

Csongrádi, A., Altorjay, I., Fülöp, G. Á., Enyedi, A., Enyedi, E. E., Hajnal, P., Takács, I., Tóth, A., Papp, Z., Fagyas, M.: Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis.
Clin. Chim. Acta. 513, 50-56, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Biochemistry (medical)

Q1 Clinical Biochemistry

Q1 Medicine (miscellaneous)

21.

Bánhegyi, V., Enyedi, A., Fülöp, G. Á., Oláh, A., Mányiné Siket, I., Váradi, C., Bottyán, K., Lódi, M., Csongrádi, A., Umar, M. A. J., Fagyas, M., Czuriga, D., Édes, I., Pólos, M., Merkely, B., Csanádi, Z., Papp, Z., Szabó, G., Radovits, T., Takács, I., Tóth, A.: Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart.
Cells. 10 (7), 1-13, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

22.

Fagyas, M., Kertész, A. B., Mányiné Siket, I., Bánhegyi, V., Kracskó, B., Szegedi, A., Szokol, M., Vajda, G., Rácz, I., Gulyás, H., Szkibák, N., Rácz, V., Csanádi, Z., Papp, Z., Tóth, A., Sipka, S. i.: Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19.
GeroScience. 43 (1), 19-29, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Aging

Q1 Cardiology and Cardiovascular Medicine

D1 Complementary and Alternative Medicine

D1 Geriatrics and Gerontology

D1 Veterinary (miscellaneous)

23.

Fülöp, G. Á., Oláh, A., Csípő, T., Kovács, Á., Pórszász, R., Veress, R., Horváth, B., Nagy, L., Bódi, B., Fagyas, M., Helgadottir, S. L., Bánhegyi, V., Juhász, B., Bombicz, M., Priksz, D., Nánási, P. P. i., Merkely, B., Édes, I., Csanádi, Z., Papp, Z., Radovits, T., Tóth, A.: Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
Basic Res. Cardiol. 116 (1), 24, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

24.

Dzsudzsák, E., Sütő, R., Pócsi, M., Fagyas, M., Szentkereszty, Z., Nagy, B. J.: Profiling of lactate dehydrogenase isoenzymes in COVID-19 disease.
EJIFCC. 32 (4), 432-441, 2021.

DEA

25.

Hajnal, P., Kiss, H., Tóth, A., Umar, M. A. J., Fagyas, M., Édes, I. F., Papp, Z.: Biochemical method for measuring efficacy of thrombin inhibitors.
In: Proceedings of the EFOP-3.6.2-16-2017-00006 (LIVE LONGER) project /Ed. Rakonczay Zoltán, Kiss Lóránd, University of Szeged, Szeged, 90, 2020.

DEA

Publication list